missing translation for 'onlineSavingsMsg'
Please login to your online account to display your discounted pricing
The L363 antibody has been reported to neutralize iNKT cell activation by α-galactosylceramide:CD1d complexes.Description & Specifications
DescriptionThis L363 monoclonal antibody reacts with α-galactosylceramide bound to the mouse MHC class I-like protein CD1d. This complex is recognized by invariant natural killer T (iNKT) cells, a subset of T lymphocytes that expresses the invariant TCR α chain Vα14Jα18. Activation of iNKT cells leads to production of Th1 and Th2-associated cytokines as well as dendritic cell maturation.
The L363 antibody has been reported to neutralize iNKT cell activation by α-galactosylceramide:CD1d complexes.
|alpha GalCer:CD1d complex|
|aqueous buffer, 0.09% sodium azide, may contain carrier protein/stabilizer|
|alpha GalCer-CD1d complex, alphaGalCerCD1d complex, alpha galcer-CD1d complex, alpha-galactosylceramide, alpha galactosylceramide, CD1d|
|Store at 2-8°C. Do not freeze. Light-sensitive material.|